Pullan L M, Powel R J
Department of Pharmacology, ICI Pharmaceuticals Group, ICI Americas Inc., Wilmington, DE 19897.
Neurosci Lett. 1992 Dec 14;148(1-2):199-201. doi: 10.1016/0304-3940(92)90838-x.
We compared, for a number of ligands to the two receptors, the displacement of [3H]strychnine binding to the glycine-gated chloride channel of spinal cord and brainstem synaptic membranes to the displacement of [3H]glycine binding to the NMDA receptor complex of hippocampal and cortex synaptic membranes. Glycine and beta-alanine are recognized by both receptors. In the NMDA receptor glycine antagonists, the kynurenic acids, most of the quinoxalinediones, and the (R)-enantiomer of HA-966 had little affinity at the strychnine-sensitive site. Surprisingly, the quinoxalinedione widely used as an AMPA (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptor antagonist, NBQX (2,3-dihydro-6-nitro-sulfamoylbenzo[f]quinoxaline-2,3-dione) displaced [3H]strychnine binding (IC50 = 11 microM) and to a lesser extent [3H]glycine binding (IC50 = 119 microM). Of the compounds tested, only strychnine, brucine, taurine and (S)-HA-966 were more potent displacers of [3H]strychnine than of glycine binding. Generally, the two glycine recognition sites appear to have remarkably different structural requirements.
我们比较了多种与这两种受体结合的配体,[3H]士的宁与脊髓和脑干突触膜甘氨酸门控氯离子通道的结合位移,以及[3H]甘氨酸与海马和皮层突触膜NMDA受体复合物的结合位移。甘氨酸和β-丙氨酸可被这两种受体识别。在NMDA受体甘氨酸拮抗剂中,犬尿喹啉酸、大多数喹喔啉二酮以及HA-966的(R)-对映体在士的宁敏感位点几乎没有亲和力。令人惊讶的是,广泛用作AMPA(α-氨基-3-羟基-5-甲基异恶唑-4-丙酸)受体拮抗剂的喹喔啉二酮NBQX(2,3-二氢-6-硝基-氨磺酰基苯并[f]喹喔啉-2,3-二酮)能取代[3H]士的宁结合(IC50 = 11 μM),对[3H]甘氨酸结合的取代作用较弱(IC50 = 119 μM)。在所测试的化合物中,只有士的宁、马钱子碱、牛磺酸和(S)-HA-966对[3H]士的宁的取代作用比对甘氨酸结合的取代作用更强。一般来说,这两个甘氨酸识别位点似乎具有明显不同的结构要求。